PTSD & Trauma
TMS for Combat-Related PTSD: Systematic Review and Meta-Analysis
Grade DSystematic review and meta-analysis2026
What did this study find?
This review pooled seven studies with 963 participants with combat-related PTSD. Symptoms fell substantially after TMS within treated groups, but in the three trials comparing active TMS with sham, the difference was not statistically significant. The authors concluded that the specific advantage of TMS over sham remains uncertain.
What are the details of this record?
- Full citation
- Virto-Farfan H, Váscones-Román FF, Rivera V, et al. Efficacy of transcranial magnetic stimulation in the treatment of combat-related PTSD: a systematic review and meta-analysis. Front Psychiatry. 2026;17:1756576. doi:10.3389/fpsyt.2026.1756576.
- Journal
- Frontiers in Psychiatry
- Authors
- Virto-Farfan H, Váscones-Román FF, Rivera V, Karpenko O, Bochkina E, Parshakova E, Sinev A, Tafet GE, Pacheco-Barrios N
- Study design
- Systematic review and meta-analysis
- Sample size and population
- 7 studies, 963 participants with combat-related PTSD
- Evidence grade
- Grade D on the BioReg grading scale
- Reported findings
- Within-group symptom reduction after TMS was large, but the three sham-controlled trials (116 participants) showed a non-significant pooled difference against sham (MD -3.83, 95% CI -16.32 to 8.65). The authors state a substantial portion of improvement may reflect non-specific or shared therapeutic factors.
- PubMed
- PMID 41868833
- Related categories
- PTSD & Trauma (category grade D to A- (TMS) / B to A- (HRV biofeedback) / F (PEMF))
A positive PEMF study is not evidence for a specific device unless the signal parameters studied, frequency, intensity, waveform, and exposure duration, are reasonably comparable to what that device produces. Where this record does not list those parameters, the source report did not publish them. See the grading methodology. Library last reviewed 2026-08-27.